Biotechnology

Imperial’s interdisciplinary expertise in biotechnology leads the UK field and spans many disciplines. Many of our experts work together as part of the Industrial Biotechnology Hub and Agri-Net which are dedicated to developing innovative solutions for industry and government agencies.

Areas of expertise include…

 

Biotechnology

Synthetic biology, biocatalysis and metabolic engineering, bioinformatics, metabolomics, proteomics, glycomics, nanotechnology, imaging, image analysis and information systems, artificial bioactive material and implants plus neurotechnology.

 

Applied Biosciences

Bioenergy/biorenewables, bioremediation and waste treatment, bioprocessing and bioseparations, biologics, implants, regenerative medicine and tissue engineering, agri-food, brain-related illnesses and blast injury.

 

Microbial Strain Engineering, Design and Improvement.

With increased environmental and economic constraints on industries, the bioproduction of molecules is becoming a sustainable alternative to traditional methods. To scale it up to industrial production, we still need significant improvements in the methods, using genetic engineering and metabolic engineering.

Engineered micro-organisms have a wide range of applications in

  • Oil and Gas – e.g. production of biodiesel, biokerosene, hydrogen, and electricity from renewable sources
  • Pharmaceuticals – e.g. production of active compounds, biosensors, microbiome engineering
  • Chemicals – e.g. production of bulk chemicals or high value compounds
  • Engineering – e.g. production of novel materials and biological circuits
  • Defence

Dr Rodrigo Ledesma-Amaro’s group at Imperial have a vast knowledge of microbial metabolism, and its regulation, in organisms ranging from yeast and fungi to bacteria. Through engineering-based improvements – such as increasing resistance to inhibitors, enabling the use of low-cost substrates and maximising the production of a desired compound – they can ‘tailor’ micro-organisms to perform desired tasks in a cost-efficient manner – and guide you on the downstream process.

The group’s expertise includes:

  • Development of synthetic biology, metabolic engineering and molecular biology tools.
  • Rational metabolic engineering for bioproduction.
  • Metabolic modelling as a tool to identify engineering targets.
  • Decreasing bioproduction cost by strain improvement at different levels.
  • Reliable chassis strains generation.
  • Selecting the best host for each product and process.
  • High-throughput strain improvement techniques.

 

Experts include:

Dr Rodrigo Ledesma-Amaro – leads a research group at the interface of synthetic biology and metabolic engineering. His expertise includes microbial biotechnology and communities, applications in industrial biotechnology and biomedicine.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research.

Who to contact:

Sue Tuttlebury

Sue Tuttlebury

Engagement Manager

For Business & finance, Maths, Medicine, Pharmaceuticals, Public & Global Health, Environment & Climate Change

+44 (0)20 7594 6559

Email me

All areas of expertise:

Related Insights

The search for a cure

The search for a cure

For the past 25 years Imperial has been at the heart of the hunt for a cure for HIV. This is the story of that search – of the highs, the lows, the setbacks and the breakthroughs. read more

Modelling an unprecedented pandemic

Modelling an unprecedented pandemic

During the COVID-19 pandemic, scientists tried to understand the behaviour of the tiny virus particles as well as their effects on very large numbers of human hosts, attempting to bridge these two worlds coherently. But ‘the science’ isn’t a singular entity: it’s highly collaborative, consensus based – and yes, subject to uncertainty. read more

Factories of the Future

Factories of the Future

Additive manufacturing is an automated production process enabling complex 3D designs to be transformed into physical objects. Read about the benefits and implications. read more

Related case studies

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Structures under extreme loading

Structures under extreme loading

The consultants shared their expertise in seismic assessment and design to support the development of EN1998, also known as Eurocode 8. read more

Twenty20 cricket bat testing

Twenty20 cricket bat testing

The consultants shared expertise and testing in line with MCC rules to help Mongoose develop the MMi3 cricket bat which is an improvement on the standard cricket bat. read more

Latest news

Improving service through bus priority schemes

Improving service through bus priority schemes

Transport Strategy Centre (RTSC) study investigates the use of priority measures for bus services in 14 cities across Asia, Australia, Europe and North America and provides best practice for decision makers charged with improving service and efficiency. read more

FREE Congenital Anomalies webinar – LIVE 25 April

FREE Congenital Anomalies webinar – LIVE 25 April

Register for the second in our series of four, LIVE, educational webinars exploring Fetal Medicine. We will explore the common (and less common) structural, chromosomal and genetic congenital abnormalities. Delivered by Imperial’s Professor Christoph Lees, and supported by GE HealthCare. read more

International Women’s day

International Women’s day

Monday March 8th celebrates the social, economic, cultural and political achievements of women, globally and this year's theme reminds us to challenge and call out gender bias and inequality. We've asked some Imperial role models how they #ChoosetoChallenge. read more